Thank you. Good morning, and welcome to Octave's second quarter 2026 call to discuss financial results.

Speaking today will be Claude LeBlanc, President and CEO, and David Trick, Chief Financial Officer. They will discuss the financial results of our business and the current market environment.

After prepared remarks, we'll take your questions. Also available for Q&A today will be executives from our Insurance Distribution segment.

For those of you following along on the webcast during the prepared remarks, we will be highlighting some slides from the investor presentation, which can be located on [our website?] .

Our call today includes forward-looking statements. The company cautions investors that any forward-looking statement involves risks and uncertainties, and it is not a guarantee of future performance.

Actual results may differ materially from those expressed or implied in the forward-looking statements due to a variety of factors. These factors are described [in the / under?]

forward-looking statements in our earnings press release and in our most recent 10-Q and 10-K all with the SEC. We do not undertake any obligation to update forward-looking statements.

Also in our prepared remarks or responses to questions, we may mention some non-GAAP financial measures. Reconciliation to those non-GAAP measures are included in our recent earnings press release, operating supplement, and other materials available in the Investors section on our website, octavegroup.com.

Now we would like to turn the call over to Mr. Claude LeBlanc.

Thank you, Karen, and good morning, everyone. I am pleased to report that Octave Group delivered another strong quarter, reflecting continued momentum across our platform and disciplined execution against our strategic priorities.

Our Insurance Distribution business continued to scale at an attractive pace, supported by strong organic growth and the benefits of recent strategic investments. At the same time, our Specialty Insurance segment showed continued operational progress and improving financial performance.

Turning to our results for the quarter. Our core Insurance Distribution business remains firmly on track with strong momentum demonstrated by revenue growth of 77% for the second quarter, which included organic growth of 44% and the impact of the acquisition of Armodacare.

Our second quarter Insurance Distribution's adjusted EBITDA was $10 million, representing a near fourfold increase year-over-year, bringing our year-to-date adjusted EBITDA to $35 million. This reflects an adjusted EBITDA margin of approximately 26%, which expanded over 12 percentage points from 13% a year ago.

Based on the continued and accelerated growth of our Insurance Distribution segment, we are adjusting our 2026 guidance for our two key metrics: organic growth and adjusted EBITDA. David Trick will provide more details on all of our guidance adjustments later in the presentation.

Included in these results is strong performance from our class of 2024 and 2025 MGAs, which continued their growth trajectory this quarter. We remain confident that these MGAs, which remain in the early stages of scaling, will drive material EBITDA expansion as they scale through 2028 and beyond.

Our specialty Property and Casualty segment continued to benefit from the early actions we have taken to reposition the platform, delivering adjusted EBITDA of $1.8 million for the quarter. We continue to strengthen the quality of Everspan's portfolio while positioning the company to generate increasingly attractive earnings as premium growth and underwriting improvements continue to compound.

The business will remain well positioned to support both third-party programs and select Octave-sponsored opportunities while delivering sustainable long-term value for shareholders. In conjunction with this, we are investing in the leadership and specialized capabilities needed to support Everspan's growth.

As announced earlier this week, we have hired three new senior leaders at Everspan Group: David Kenyon, Head of Reinsurance, who recently joined the company; and Beben Grizsland, Chief Underwriting Officer; and Clay Stuart, Chief Operating Officer, who will be joining us shortly. David, Beben, and Clay each bring deep expertise in their respective fields.

Together, they will strengthen our ability to scale Everspan while maintaining our focus on underwriting discipline, strong partnerships, and operational excellence. Turning to the market environment.

Broadly, the U.S. and global P&C insurance markets continue to soften.

Property markets are being shaped by abundant capacity. The wholesale large property segment is leading the pullback with rates down 10 to 20% year-on-year, while low cat-exposed SME property markets are experiencing more muted softening.

Notably, this is happening after years of increases which gave rise to a strong technical price foundation. As a result, notwithstanding these rate reductions, price adequacy remains intact for our well-underwritten portfolios.

The London market large casualty products are operating against a backdrop of robust competitive pressures, although they are demonstrating better rate resilience than large property lines. By contrast, casualty SME classes, including general liability and certain commercial auto risks, as well as targeted specialty classes, continue to show mid-single to double-digit rate progression and represent an attractive opportunity for expansion.

A&H continues to benefit from constructive positive rate trends and strong secular growth in certain markets. In this market environment, our portfolio strategy remains a key differentiator.

We have intentionally built a diversified platform across A&H, Specialty P&C, and select property lines, giving us multiple sources of growth and reducing our dependence on any single product class or market cycle. This diversification is especially important in the current environment, where our A&H businesses continue to provide a growing earnings base that is largely uncorrelated with broader P&C pricing cycles.

This breadth allows us to manage concentration risk, reposition where appropriate, and continue pursuing profitable growth in areas where market fundamentals remain attractive. Equally important, our MGA model is built around experienced underwriting leaders who have managed through prior market cycles.

Their expertise, combined with disciplined portfolio management and strong capacity relationships, enables us to responsibly deploy underwriting capital on behalf of our partners while protecting margins and supporting sustained growth. Beyond portfolio diversification and experienced underwriting leadership, our growth is supported by the profile of our portfolio companies and our portfolio bias towards areas where growth opportunity remains strong.

Since the start of 2024, Octave has launched nine MGAs, representing 40% of our MGA portfolio. Following an MGA launch, there is an inherent strong growth trajectory which typically continues for at least five years, and in many cases well beyond that window.

MGA launches typically break even and start to deliver positive EBITDA after 18 to 24 months. In contrast, our mature MGAs are driving growth through a deliberate proactive strategy: expanding distribution, repositioning towards the strongest underwriting opportunities, and broadening capacity access within core products.

We are leveraging MGA and corporate leadership expertise alongside targeted talent recruitment to drive product growth. Bolt-on teams, a strategy we're executing across multiple platforms, provides an efficient low-cost route to growth, rivaling smaller new MGA launches.

Taken together, the diversity of our portfolio, the profile of our MGAs, and the quality of our underwriting talent give Octave a differentiated ability to perform through market cycles. We believe this positions us well to deliver above-market organic growth today while preserving meaningful upside as market conditions evolve.

Finally, a brief update on our AI and data strategy. We view AI as both a growth enabler and an efficiency tool.

Applied thoughtfully, it strengthens our underwriting capabilities, improves speed and consistency across our enterprise, and helps our teams focus their time on high-value risk selection and client engagement. During the second quarter, we collaborated with Cytora to develop and launch our proprietary AI-driven underwriting platform, turning submissions into decision-ready risks, allowing us to review opportunities faster and with greater underwriting quality.

It is currently active in a number of our U.S. MGAs that write management, financial, and professional liability programs.

To date, the results are very encouraging. In one clear example of underwriting efficiency and acceleration, we have reduced submit-to-quote time from several hours to approximately 7 minutes.

Over time, we expect this capability to reduce manual effort, accelerate underwriting decisions, improve service levels, and bring additional MGAs to market more quickly. We expect to complete the implementation across our remaining applicable U.S.

MGAs in the second half of this year. I will now turn the call over to David to review our second quarter results.

David?

Thank you, Claude. Good morning, everyone.

For the second quarter of 2026, Octave reported a net loss to shareholders of $14.4 million, or 33 cents per share, an improvement of over $6 million, or 9 cents per share, compared to the net loss to shareholders of $20.5 million, or 42 cents per share, reported in the second quarter of 2025. Consolidated EBITDA and adjusted EBITDA to shareholders improved to a negative $1.7 million and a positive $3.7 million, compared to a negative $9.8 million and negative $4.6 million, respectively, in the second quarter of 2025, representing an $8.1 million and $8.3 million improvement, respectively.

The consolidated adjusted net loss to shareholders was $1.8 million, or 4 cents per share, compared to a loss of $10.6 million, or 22 cents per share, in the second quarter of 2025, an improvement of $8.7 million, or 18 cents per share. The results for the quarter, led by Insurance Distribution, also reflect improved results at Everspan as well as our corporate operations.

Total revenue for the Insurance Distribution segment grew 77% to $58.4 million in the second quarter of 2026. Organic growth of 44% and the October 2025 acquisition of Armodacare were the drivers of the substantial increase in revenue.

Organic growth was aided by the diversity of our business, including de novos launched over the last two years and certain specialty product lines, which more than offset some of the softness we experienced in certain markets such as energy and D&F property. The Insurance Distribution segment's net loss to shareholders decreased to $3.7 million in the quarter, compared to a net loss of $7.7 million in the prior year quarter, an improvement of $4 million.

Insurance Distribution's adjusted EBITDA to shareholders grew nearly fourfold to $9.8 million compared to $2.5 million in the prior year period, driving related margins to 16.8% from 7.6%, respectively. Adjusted net income to shareholders swung positive to $4.6 million, compared to a net loss of $3 million in the second quarter of 2025.

Our Insurance Distribution results for the quarter were driven by a number of factors, including the October 2025 acquisition of Armodacare, organic growth across our diverse group of MGAs, higher profit commissions reflecting continued underwriting discipline, the acquisition of an additional 10% of Octave Ventures at the end of the first quarter, and a near $3 million reduction in interest expense resulting from both the reduction of debt and lower financing costs. Our results for the quarter also reflect our continued investment into de novo MGAs, which suppressed EBITDA to shareholders by about $1.1 million in the quarter, accounting for about two points of EBITDA margin.

Turning to Everspan. Gross and net premiums written and premiums earned in the quarter were $95 million, $23 million, and $22 million, down 2% and up 52% and 34%, respectively.

The actions we've been taking to reposition Everspan helped bring down our current quarter loss ratio to 61.4%, with our active programs running at about a 59% loss ratio. This represents a 640-basis-point improvement in our reported loss ratio compared to the second quarter of 2025.

Our G&A expense ratio also declined year-over-year to 9.4% from 16%, driven by lower expenses and earned premium growth. Reduction in the loss and G&A expense ratios were partially offset by higher acquisition costs due to embedded sliding scales on certain programs that we believe will provide more stable underwriting results going forward.

Together, these results led to a reduction in the combined ratio to 100.6%, compared to 106.7% last year, above our long-term objectives, but progress towards our goal. For the second quarter of 2026, Everspan produced pretax income of $1.2 million and adjusted EBITDA was $1.8 million, double and nearly triple, respectively, the results from the prior year period.

Continued expense reduction and containment initiatives at corporate also contributed positively to our improved second quarter results. Reported GAAP corporate expenses declined from $14 million in the second quarter of 2025 to $12 million this quarter, a 14% improvement.

In addition, adjusted expenses declined to $7.9 million from $8.3 million in the prior year comparable period. The difference between reported expenses and adjusted expenses in the current quarter was mainly attributable to $1.1 million of acquisition, integration, severance, and restructuring expenses, and $2.7 million of equity compensation.

We continue to evaluate all expenses in an effort to trend our adjusted expenses downward toward our longer-term goals. Turning to guidance.

We are updating several key items that reflect the continued strength of our Insurance Distribution business and the ongoing evolution of our platform. Within our Insurance Distribution segment, we are raising guidance for both of our key operating metrics.

We now expect organic growth of 25%-plus, up from our prior expectation of 20%-plus, and are increasing adjusted EBITDA guidance to $45 million from $40 million. These increases reflect the diversity and continued momentum of our distribution platform.

At Everspan, we are revising our adjusted EBITDA guidance to $6 million from $7.5 million. This change is primarily driven by higher-than-expected acquisition costs associated with the mix of newer programs we are onboarding.

While these costs impact near-term profitability, we believe these programs will produce more attractive long-term economics through lower and more stable loss ratios, supporting a stronger and more durable earnings profile over time, particularly as we build scale. $6 million of adjusted EBITDA would represent a 58% increase over 2025's adjusted EBITDA of $3.8 million.

We are also updating our adjusted net income per share guidance to a range of 15 cents to 20 cents per share, compared with our prior expectation of 50 cents per share. This revision reflects updated estimates for interest expense, depreciation, taxes, and a more refined allocation of noncontrolling interests across the business.

Importantly, our outlook continues to represent a significant milestone for the company. We expect 2026 to be the first year we generate positive adjusted net income per share, excluding the legacy financial guarantee business, since launching our P&C strategy in 2021.

At the midpoint of our revised guidance, this represents approximately a 76-cent-per-share improvement from our 2025 adjusted loss of 58 cents per share, driven by the continued growth and increasing earnings power of our Insurance Distribution platform. All other guidance remains unchanged.

I will now turn the call back to Claude.

As we move into the second half of 2026, I am confident in the strength, scalability, and resilience of our business model. While the market environment remains dynamic, we are executing with discipline, maintaining our focus on underwriting quality, portfolio management, and responsible growth.

These results reinforce our confidence in Octave Group's long-term opportunity. We believe the foundation we are building positions us well to deliver sustained profitable growth and advance our vision of becoming a leading specialty insurance distribution company.

Operator, I would now like to open the call to questions.

Thank you. Good morning.

I'm calling in for Mark Hughes. How would you characterize the pipeline for startup MGAs, and then how is the pipeline for the class of 2027 shaping up if you have a line of sight there?

Good morning, Max. Where we stand for '26, I think we indicated that we thought there would be a lower number of MGAs launched this year.

We haven't launched any to date, although we still expect to, but we indicated one or two for '26. This came off the large number that we launched in the class of '24 and '25, where we launched nine, representing roughly 40% of our total MGA portfolio.

It was our expectation to keep that number lower this year as we focus on the large number of MGAs launched in that period. Roughly close to 75% of our organic growth this quarter was delivered by the class of '24 and '25.

Those MGAs are just beginning at the early stages of scaling their platforms and really taking hold of the growth and also beginning to deliver EBITDA. Roughly half the MGAs of that class are delivering EBITDA at this point in time, and we expect more to start contributing, and contributing much more meaningfully, as we get through to the end of the year and into '27.

Right now, as we kind of look at the trajectory in terms of our target EBITDA, looking at '28 that we put out of $80 million, a significant percentage of that will come out of the class of '24-'25. Coming back to your specific question on '26 and '27, we're still targeting a relatively modest number of MGAs in '27.

I think we probably in a range of two to four in terms of launch. We do have a pipeline of startups that we continuously evaluate for launching.

We're very selective, of course, in choosing the MGA portfolios that we're looking at. We've also been refining our integrated operational platform that we believe will enhance our ability to launch MGAs even quicker than we had in the past and get them to scale sooner, which has also been a major initiative that we've been focused on in '26 and have made tremendous progress in the last number of months.

Again, the pipeline is deep, but the class of '24-'25, being a focus on those. As I mentioned in my prepared remarks, the fact that we were adding teams to those MGAs as well, not just those, but others that we acquired, has been an alternative way to grow and scale, what I'll say, the small to mid-sized MGA launches.

We're able to get them up and running much quicker by adding teams to existing MGA platforms, and that has been a key source of growth also for this year as well.

Great. That's helpful, thank you.

Then in terms of capacity, what are your observations around your current partners and then the market in general's appetite around providing more capacity?

Maybe I'll let Naveen Anand, who's with us this morning, to answer that.

Good morning, Max. Overall, I think from a capacity standpoint, it's really goes down to underwriting results and our underwriting results across all of our general have been good, and as a result we see capacity being attractive and attached to our portfolios and our platforms.

We expect that we'll continue to see strong capacity support as we go forward into '26, remaining '26 and certainly into '27 across both our start platform today supporting our venture businesses as well as our more established MGAs in our parts

portfolio. I'd just add that we are continuing to broaden and diversify our capacity.

Again, our model is a curated capacity model, and we continue to add capacity partners. Most quarters we're adding at least one or more, so that's part of our strategy and something that we will continue to progress as we scale the platform.

Thank you. Then I guess turning to rates, I'll start with non-cat property.

What sort of pricing are you getting there? Then when you look at where we are in the cycle, do you think we're anywhere near a floor?

What are your observations on that market?

Oh Max, this is Naveen again. Generally we're seeing rate declines in this sort of 10 to 20% range as Claude has mentioned in that sort of property lines, both primarily in large account property lines and more on the cat-exposed property lines.

I expect we're still in the relatively early innings, assuming, obviously things can change quickly if there are other large cat events and things can change market from that standpoint. At this point, we expect that to continue to soften as we move forward into the remainder of '26 into '27, particularly the cat events don't happen from that standpoint.

As we mentioned, our portfolio is much more geared to the non-cat and non-large account, more the SME side of the business mix. I think for us, when we kind of look at the average, it's probably closer to 5 to 10 or the lower end of that range, just given the business mix that our portfolios are focused on.

We still are having strong growth in some of our property MGAs, again the ones that are focused on the E&S SME space. Again, it is a mix for us, and I'd say that more muted in terms of the price impacts, although there are a few that, as Naveen mentioned, have been in the flow of the larger account D&F markets that have had some impact that are more in line with market, but that is a small percentage of our portfolio.

At Everspan, I know excess liability is a decent part of the mix there. What are your observations pricing there?

Is there any incremental competition you're seeing? If so, where do you see that coming from and do you still think pricing is running ahead of loss trends?

Max, this is Naveen again. Generally we're still seeing positive rate environment in the excess liability.

It is moderating a bit in terms of as each quarter goes on. It's still generally in line with and better than loss costs from that standpoint.

Obviously it's dependent on portfolio by portfolio on that basis. For the portfolio that we have and the targets that we had in Everspan, we're generally seeing positive rate environment so that excess liability portfolio is working to see the loss cost.

I'd say another trend with Everspan is we are seeing a broadening of programs that we're seeing. I think also signed the times with the market conditions that we're seeing again certainly some casualty the more specialty programs that are differentiated in the marketplace.

I think the selection and breadth of programs that we're seeing has improved and also the pipeline has improved overall. I think the Everspan platform, we do see some strong growth for the year.

Again, we're not chasing growth and we're being very selective there as well, but we are seeing a very much higher quality and deeper and broader breadth of opportunities in the program space for Everspan. Then

last one from me and I'll hop back in the queue. Is there any associated investment or cost related to the rollout of the new AI tool to your remaining MGAs?

As I mentioned on the prior calls, the implementation, customization, and also the development of the AI tools that we have in our platform, we're in the low to mid single-digit millions for the year targeted for that. When you add the initial costs that we're encountering in connection with technology upgrades and also the implementation of technologies across the platform to support that, that is an additional amount that is also in this low to mid single-digit millions.

Those are going to be costs that are more one-time in nature. Again, I always say that there could be obviously additional initiatives that we'll be looking at next year certainly, but for this year I think this would be one of the larger additions in terms of AI and technology that we have in our sort of forecast period.

We will see some of those costs begin to peel off early next year and by mid next year, I think a meaningful percentage in the millions will be discontinued. We also expect to benefit from those investments, obviously, and there'll be significant cost benefits as well as revenue benefits that will be coming out of that that will far offset any of the implementation costs that we've put in today.

Great. Thank you for taking my questions.

Thanks, Max.

Hey, good morning. Thanks for taking our questions.

The first one here with Armodacare and some of your other MGAs, the accident and health is a major line of business for you guys. Market commentary tends to generalize pricing and conditions talking about the property and casualty buckets, but A&H does have some of its own drivers.

Can you spend a minute just talk about the market conditions that you're seeing in A&H and as that relates to inputs to your future organic growth opportunity in that line? Thanks.

Sure. Sure.

Hi Tommy, this is Naveen. A couple points, A&H is a pretty broad market segment, right?

Armodacare is focused on the excess benefits and benefits area, and then our exchange benefits platform is primarily focused for stop loss. Then we've got some other focus in other ancillary lines within A&H.

For our key areas, we're seeing strong secular growth. There are strong sort of underlying trends that are driving both the ESL market and the benefits market.

Those growth trends will continue to support organic growth as we move forward. In addition to that, we're seeing positive rate environment in those sectors as well, generally in the double-digit range, low double-digit range, low teens to high single digits.

Again we expect that to continue as we move forward into '26 and into '27 based on the sort of underlying trends within those segments. It's a important part of our portfolio.

It's about a third of our portfolio today and a important contributor to our results and balance to some of this challenges in the broader P&C cycles.

Got it. Thanks for that color.

Then switching over, the Everspan book continues to charge ahead toward its mid-teens for ROE at scale. Could you just remind me what your definition of scale is in that business, and is there any chance that fronting economics could change for either better or worse over the coming years as you gain scale?

Then just lastly, does that ROE that you're targeting equate to a specific combined ratio relative to the 97% adjusted combined that you did in the first half of the year?

In terms of scale, I think the way we had again modeled out the growth of the platform, given the way that we've staffed and implemented systems and technologies to support a business that was always intended to be a hybrid platform, not a pure fronting platform, we do have a higher overhead costs associated with the business. Our target to scale was somewhere north of $500 million of premium, which we'll be approaching that this year, but not quite there.

I think and from there forward, I think we'll start seeing a lot less impact of that fixed cost drag on the combined ratio in earnings and EBITDA going forward. I think once we get past that, I think we still probably this year we'll have a few points of drag associated with scale, but again that will begin to ameliorate next year.

I think this year we're probably being in the mid-4s sort of in premium.

410 is our guidance.

410 is our guidance, 410 is where we're targeting. Again, I think we'll be in that range, possibly a little higher.

Next year, I would expect us to be closer to that $500 million scale number. In terms of the second question, maybe I'll let David hit on the combined.

On the combined ratio, what we've said in the past is that we're looking at sub-95 combined ratio, as a casualty-focused business, you expect our loss ratios to be a little higher than businesses that have heavy property books but more cat-exposed. We've added some property exposure to the portfolio at this point, which is certainly starting to see the benefit of in the loss ratio, and expect to see that further in the remainder of the year.

Let's say between 90 and 95 is what our target is, which is in overall function of getting those loss ratios down and more stable, and what Claude had mentioned in terms of just continuing to scale the business from an expense ratio standpoint.

Thanks. Then just last question to switch topics one more time.

A lot of brokers and MGAs are benefiting from strong profit commissions or contingents. You guys had a nice uptick in the first half of the year.

Was any of the change in guidance contemplating a higher level of profit commissions? Then do you guys have line of sight to what you think that contingents could be in the second half of the year, either on a absolute dollar basis or as a percentage of distribution revenue?

Thanks.

The way we account for our profit commissions, we scale into our numbers that we're seeing, we try to avoid a lot of volatility. I think based on our calculations, in our original guidance included profit commissions close to the levels that we're seeing here today.

We baked in a little bit additional profit commissions for one of our businesses, but I wouldn't say it was material. We think we'll have a good year on P&Cs, particularly for the lines of businesses that are driving it, which tend to have more stable loss ratios.

Thanks.

Thanks. Good morning.

Our flight hasn't left yet, I thought I'd sneak one in. On the Everspan, you described hiring some new executive talent.

Sounds like your growth outlook for 2027 is pretty robust. I think you added a number of programs just this quarter.

Could you talk about the quality control on that underwriting? That's obviously a point of risk for anyone with programs and new programs.

What are you doing to give yourself confidence that the underwriting there is going to be high quality?

Again, I think the talent we're bringing in, with Beben, who has deep experience and been a chief underwriting officer, and her breadth of experience was actually one of the things that attracted us to her, and she's replacing Darwin, who was in that role as chief underwriting officer and chief reinsurance officer. Darwin also has extensive experience, years of experience.

The broadening of the team and the depth of the team along with our claims team, which is also very important in terms of managing our loss ratios in the underwriting, I think has really expanded dramatically over the last year. I think we feel very confident of the experience and breadth of the team, and to the extent there are programs that come in that we require additional diligence, we also don't shy away from reaching out and bringing in additional resources and expertise to help us on the review and underwriting of the programs.

I think our approach to the underwriting, again we really are a gross line underwriter, we really focus on the full program. Again, we're not a fronting, pure front platform.

I think from our perspective, we were robust, but I think we're now that much more robust, and the claims oversight that is done and managed throughout a program monitoring, and the audits that we do on programs after 90 days from commencement, and thereafter yearly if not more depending on the program, I think gives us confidence that our selections will be good as well as our ongoing oversight and monitoring of exposures.

Appreciate that. Thank you.

Thanks, Mark.